A 34 year old man with a long history of asthma is referred to pulmonologist. The physician decides to prescribe zileuton. The mechanism of action of this drug is to:
**Core Concept**
The question is testing the mechanism of action of zileuton, a medication used in the management of asthma. Zileuton is a specific type of drug that inhibits the enzyme responsible for the synthesis of leukotrienes, which play a significant role in the pathophysiology of asthma.
**Why the Correct Answer is Right**
Zileuton works by inhibiting 5-lipoxygenase (5-LOX), an enzyme that catalyzes the conversion of arachidonic acid to leukotriene A4 (LTA4). This is a critical step in the synthesis of cysteinyl leukotrienes, such as LTC4, LTD4, and LTE4, which are potent bronchoconstrictors and pro-inflammatory mediators in asthma. By inhibiting 5-LOX, zileuton reduces the production of leukotrienes, thereby alleviating symptoms of asthma.
**Why Each Wrong Option is Incorrect**
**Option A:** This is not a known mechanism of action for zileuton. While other asthma medications may have this effect, it is not relevant to zileuton's mechanism.
**Option B:** This is not accurate. Zileuton does not work by inhibiting histamine release. Histamine is another key player in allergic reactions and asthma, but zileuton targets a different pathway.
**Option C:** This is not correct. Zileuton does not work by inhibiting the phosphodiesterase (PDE) enzyme family. PDE inhibitors are a different class of asthma medications.
**Clinical Pearl / High-Yield Fact**
Zileuton is a unique medication among asthma therapies because it targets the 5-lipoxygenase pathway, which is specific to leukotriene synthesis. This makes it a valuable option for patients with asthma who are not adequately controlled by other treatments.
**Correct Answer: C. Inhibiting 5-lipoxygenase (5-LOX) to reduce leukotriene synthesis.**